NCL Statement on the Resignation of FDA Commissioner Scott Gottlieb – National Consumers League

March 6, 2019

Media contact: National Consumers League – Carol McKay,, (412) 945-3242 or Taun Sterling,, (202) 207-2832

Washington, DC – The National Consumers League (NCL) is saddened by yesterday’s announcement of the resignation of the Food and Drug Administration (FDA) Commissioner Scott Gottlieb. Since his appointment, Commissioner Gottlieb has championed the public health, tackling tough issues like the teen vaping epidemic, the opioid crisis, and counterfeit drugs, among others.

He is also credited with accelerating FDA’s approval of generic drugs and modernizing the FDA’s review and approval process.

NCL had welcomed Gottlieb’s appointment, and was fortunate to have had the opportunity to sit down with him for a fireside chat at our December 2017 Health Advisory Council meeting. At the meeting, Gottlieb discussed how his experience as a cancer patient influenced his approach as a physician and policymaker, enhancing his understanding of the patient perspective.

Sally Greenberg, NCL Executive Director, said: “Commissioner Gottlieb will be greatly missed. We wish him all the best, and hope that the next FDA Commissioner will put the interests of consumers first by maintaining the agency’s strong oversight of the safety and effectiveness of drugs and medical devices.”

About the National Consumers League

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit